These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31046486)

  • 1. The study of methylation and single nucleotide polymorphisms of cancer-related genes in patients with early-stage ulcerative colitis.
    Chen HX; Yuan ZY; Wu KX; Liu C; Mao QD; He BG; Yuan H
    Scand J Gastroenterol; 2019 Apr; 54(4):427-431. PubMed ID: 31046486
    [No Abstract]   [Full Text] [Related]  

  • 2. Methylation status of genes in non-neoplastic mucosa from patients with ulcerative colitis-associated colorectal cancer.
    Garrity-Park MM; Loftus EV; Sandborn WJ; Bryant SC; Smyrk TC
    Am J Gastroenterol; 2010 Jul; 105(7):1610-9. PubMed ID: 20160714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Biomarker Panel to Detect Synchronous Neoplasm in Non-neoplastic Surveillance Biopsies from Patients with Ulcerative Colitis.
    Garrity-Park MM; Loftus EV; Bryant SC; Smyrk TC
    Inflamm Bowel Dis; 2016 Jul; 22(7):1568-74. PubMed ID: 27135485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloperoxidase immunohistochemistry as a measure of disease activity in ulcerative colitis: association with ulcerative colitis-colorectal cancer, tumor necrosis factor polymorphism and RUNX3 methylation.
    Garrity-Park M; Loftus EV; Sandborn WJ; Smyrk TC
    Inflamm Bowel Dis; 2012 Feb; 18(2):275-83. PubMed ID: 21425209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Status of Gene Methylation and Polymorphism in Different Courses of Ulcerative Colitis and Their Comparison with Sporadic Colorectal Cancer.
    Liu C; Yuan ZY; Yuan H; Wu KX; Cao B; Ren KY; Cui MJ; Liu JH; Chen HX; Pang YW
    Inflamm Bowel Dis; 2021 Mar; 27(4):522-529. PubMed ID: 32793962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Runt-related transcription factor 3 is associated with ulcerative colitis and shows epistasis with solute carrier family 22, members 4 and 5.
    Weersma RK; Zhou L; Nolte IM; van der Steege G; van Dullemen HM; Oosterom E; Bok L; Peppelenbosch MP; Faber KN; Kleibeuker JH; Dijkstra G
    Inflamm Bowel Dis; 2008 Dec; 14(12):1615-22. PubMed ID: 18668679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant gene methylation in non-neoplastic mucosa as a predictive marker of ulcerative colitis-associated CRC.
    Scarpa M; Scarpa M; Castagliuolo I; Erroi F; Kotsafti A; Basato S; Brun P; D'Incà R; Rugge M; Angriman I; Castoro C
    Oncotarget; 2016 Mar; 7(9):10322-31. PubMed ID: 26862732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor-alpha polymorphisms in ulcerative colitis-associated colorectal cancer.
    Garrity-Park MM; Loftus EV; Bryant SC; Sandborn WJ; Smyrk TC
    Am J Gastroenterol; 2008 Feb; 103(2):407-15. PubMed ID: 18289203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MHC Class II alleles in ulcerative colitis-associated colorectal cancer.
    Garrity-Park MM; Loftus EV; Sandborn WJ; Bryant SC; Smyrk TC
    Gut; 2009 Sep; 58(9):1226-33. PubMed ID: 19251712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromatin immunoprecipitation and association study revealed a possible role of Runt-related transcription factor 3 in the ulcerative colitis of Chinese population.
    Guo C; Yao F; Wu K; Yang L; Zhang X; Ding J
    Clin Immunol; 2010 Jun; 135(3):483-9. PubMed ID: 20392673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients With Ulcerative Colitis-Associated Colorectal Cancer.
    Toiyama Y; Okugawa Y; Tanaka K; Araki T; Uchida K; Hishida A; Uchino M; Ikeuchi H; Hirota S; Kusunoki M; Boland CR; Goel A
    Gastroenterology; 2017 Dec; 153(6):1634-1646.e8. PubMed ID: 28847750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host genetic factors, related to inflammatory response, influence the CpG island methylation status in colonic mucosa in ulcerative colitis.
    Tahara T; Shibata T; Nakamura M; Okubo M; Yamashita H; Yoshioka D; Yonemura J; Kmiya Y; Ishizuka T; Fujita H; Nagasaka M; Yamada H; Hirata I; Arisawa T
    Anticancer Res; 2011 Mar; 31(3):933-8. PubMed ID: 21498716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of RUNX3 Immunoreactivity in Non-Neoplastic Rectal Mucosa May Predict the Occurrence of Ulcerative Colitis-Associated Colorectal Cancer.
    Shinagawa T; Hata K; Morikawa T; Matsunaga K; Emoto S; Murono K; Kaneko M; Sasaki K; Nishikawa T; Tanaka T; Kawai K; Nozawa H; Fukayama M; Ishihara S
    Digestion; 2020; 101(2):156-164. PubMed ID: 30763934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [THE INFLUENCE OF TUMOR NECROSIS FACTOR ALPHA AND POLYMORPHISM OF ITS GENE (RS1800629) ON THE SEVERITY AND PROGRESSION OF CHRONIC HEPATITIS AND ULCERATIVE COLITIS].
    Bulatova IA; Tretyakova YI; Shchekotova AP; Shchekotov VV; Krivtsov AV; Nasibullina NI
    Eksp Klin Gastroenterol; 2016; (3):9-14. PubMed ID: 27301136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating methylated RUNX3 and SFRP1 genes as a noninvasive panel for early detection of colorectal cancer.
    Pasha HF; Radwan MI; Yehia AM; Toam MM
    Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1342-1349. PubMed ID: 31524773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ulcerative colitis neoplasia is not associated with common inflammatory bowel disease single-nucleotide polymorphisms.
    Connelly TM; Berg AS; Harris LR; Brinton DL; Hegarty JP; Deiling SM; Stewart DB; Koltun WA
    Surgery; 2014 Aug; 156(2):253-62. PubMed ID: 24947639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of Genetic Polymorphisms of Inflammation Response Genes on Sporadic Colorectal Cancer Predisposition Risk in Malaysian Patients - A Case Control Study.
    Ankathil R; Mustapha MA; Abdul Aziz AA; Mohd Shahpudin SN; Zakaria AD; Abu Hassan MR; Musa KI
    Asian Pac J Cancer Prev; 2019 Jun; 20(6):1621-1632. PubMed ID: 31244280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms of the IL-1beta and IL-1beta-inducible genes in ulcerative colitis.
    Nohara H; Saito Y; Higaki S; Okayama N; Hamanaka Y; Okita K; Hinoda Y
    J Gastroenterol; 2002 Nov; 37 Suppl 14():107-10. PubMed ID: 12572877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour necrosis factor-alpha (-308G/A) promoter polymorphism is associated with ulcerative colitis in Brazilian patients.
    Tavares M; de Lima C; Fernandes W; Martinelli V; de Lucena M; Lima F; Telles A; Brandão L; de Melo Júnior M
    Int J Immunogenet; 2016 Dec; 43(6):376-382. PubMed ID: 27528546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RUNX3 promoter methylation in colorectal cancer: its relationship with microsatellite instability and its suitability as a novel serum tumor marker.
    Nishio M; Sakakura C; Nagata T; Komiyama S; Miyashita A; Hamada T; Kuryu Y; Ikoma H; Kubota T; Kimura A; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Ochiai T; Kokuba Y; Sonoyama T; Ida H; Ito K; Chiba T; Ito Y; Otsuji E
    Anticancer Res; 2010 Jul; 30(7):2673-82. PubMed ID: 20682997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.